DSM Venturing is the corporate venture arm of Royal DSM, investing in startups in sectors of animal and human health &a; nutrition and biomed.
Business Model:
Revenue: $9.6B
Employees: 10,001-999,999
Address: Het Overloon 1
City: Heerlen
State: limburg
Zip: 6411
Country: NL
Founded in 2001, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health &a; nutrition) and biomedical.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2018 | Raycatch | Series B | - |
2/2017 | QD Solar Inc. | Series A | 0 |
9/2004 | Sciona | Series B | 4.1M |
9/2016 | Essential Medical | Series B | 14.9M |
2/2019 | Adaptive3D | Series A | - |
8/2016 | Arecor | Venture Round | 12M |
3/2013 | Arecor | Venture Round | - |
9/2022 | Rootine | Series A | 10M |
7/2021 | Leading Edge Equipment Technologies | Convertible Note | 0 |
3/2017 | NutriLeads | Series A | - |
9/2018 | Miach Orthopaedics | Series A | 22.5M |
8/2020 | NutriLeads | Series B | 0 |
4/2020 | Panaceutics Nutrition | Series A | 0 |
11/2015 | NutriLeads | Seed Round | - |
7/2015 | NovoPolymers | Venture Round | - |
3/2002 | Sciona | Series A | 4.2M |
8/2007 | Food Quality Sensor International | Series B | 5.6M |
1/2003 | Optiva | Series C | 0 |
10/2019 | Voxel8 | Series B | - |
3/2014 | Verdezyne | Venture Round | 0 |
8/2008 | Provexis | Post-IPO Equity | 2.8M |
7/2021 | Prenexus Health | Series B | 0 |
7/2021 | Additive Manufacturing Technologies | Series B | 0 |
5/2012 | Regentis Biomaterials | Series C | 0 |
12/2021 | ATRO Medical | Venture Round | 0 |
4/2006 | Sciona | Series C | 9.9M |
8/2021 | Rootine | Seed Round | 0 |
1/2023 | Miach Orthopaedics | Series B | 0 |
3/2022 | OK Capsule | Seed Round | 0 |
10/2020 | Leading Edge Equipment Technologies | Series A | 7.6M |
3/2019 | Hyalex Orthopaedics | Series A | 17M |
5/2023 | VitaminLab | Series A | - |
5/2023 | Athian | Seed Round | - |
2/2023 | Meala Foodtech | Pre Seed Round | 0 |
1/2023 | OK Capsule | Series A | 0 |
8/2012 | Segetis | Series C | 0 |
5/2023 | Incredo | Series C | 0 |
7/2017 | ATRO Medical | Series A | - |
5/2022 | inne | Series A | 0 |
5/2011 | Verdezyne | Venture Round | - |
9/2019 | Chinova Bioworks | Seed Round | 0 |
10/2019 | Additive Manufacturing Technologies | Series A | 6.4M |
9/2022 | Momentous | Series A | 0 |
2/2004 | Morphotek | Series C | 26M |
3/2014 | Isobionics | Venture Round | - |
7/2022 | Phytolon | Series A | 14.5M |
6/2021 | Brains Bioceutical | Series A | 31.9M |
9/2007 | Upfront Chromatography | Venture Round | 9.2M |
6/2022 | Chinova Bioworks | Series A | 0 |
11/2006 | IntegraGen | Venture Round | 2.5M |
9/2016 | Blue Prairie | Series A | 0 |
2/2021 | Frontier Nutrition | Series B | 6M |
11/2022 | Sun Genomics | Series B | - |
1/2010 | Segetis | Series B | 17.2M |
8/2019 | ZeaVision | Venture Round | - |
3/2021 | Deep Branch Biotechnology | Series A | 0 |
9/2022 | Octarine Bio | Seed Round | 0 |
11/2019 | Inkbit | Venture Round | 0 |
10/2013 | ChromaDex | Post-IPO Equity | 3M |
1/2015 | Interface Biologics, Inc. | Series B | - |
4/2019 | Panaceutics Nutrition | Venture Round | - |
7/2012 | Xolve | Funding Round | 2.1M |
4/2018 | Tespo | Series A | 3.5M |
2/2017 | WattGlass | Series A | - |
2/2007 | Harland Medical Systems | Venture Round | - |
3/2021 | Novum Medical | Venture Round | - |
4/2018 | Chromatic 3D Materials | Series A | - |
11/2006 | Micromuscle | Venture Round | - |
11/2007 | Ganeden Biotech | Venture Round | 0 |
3/2021 | Meatable | Series A | 47M |
11/2017 | Leading Edge Equipment Technologies | Convertible Note | 2.5M |
2/2023 | Paleo | Series A | 0 |
5/2020 | Phynova Group | Venture Round | 10.8M |
2/2009 | Viocare | Venture Round | - |
10/2010 | CellMade | Funding Round | 2.3M |
9/2018 | Novum Medical | Series C | 4.5M |
7/2015 | Natreon | Venture Round | 2.5M |
10/2014 | EyePromise | Venture Round | 3M |
8/2018 | Chinova Bioworks | Seed Round | 0 |
5/2005 | ORYXE Energy International | Venture Round | - |
8/2009 | Novomer | Series B | 14M |
6/2016 | NOMADD | Series A | 2.5M |
5/2023 | DouxMatok | Series C | 0 |
5/2023 | VitaminLab | Series A | - |
5/2023 | Athian | Seed Round | - |
2/2023 | Paleo | Series A | 0 |
2/2023 | Meala Foodtech | Pre Seed Round | 0 |
1/2023 | Miach Orthopaedics | Series B | 0 |
1/2023 | OK Capsule | Series A | 0 |
11/2022 | Sun Genomics | Series B | - |
9/2022 | Octarine Bio | Seed Round | 0 |
9/2022 | Momentous | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|